Serum Institute may alter covid shot to tackle mutant strain
Named as covishield in India, the Oxford-AstraZeneca vaccine has been rolled out in the country but is yet to receive a green signal for global use through COVAX
(REUTERS)
on Monday and Tuesday, SAGE reviewed the evidence on jab’s effectiveness on new SARS CoV-2 variants
Share Via
Read Full Story
The composition of the vaccine developed by the University of Oxford and British pharma major AstraZeneca may have to be adjusted by vaccine manufacturer Serum Institute of India, after the World Health Organization’s (WHO) Strategic Advisory Group of Experts on Immunization (SAGE) expressed concerns over the effectiveness of the vaccine against the South African mutant coronavirus strain.